Theravance Biopharma Inc (TBPH) — Capital Reinvestment Ratio
Theravance Biopharma Inc (TBPH) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($208.07 Million) in capital expenditures ($34.00K). Check TBPH intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Theravance Biopharma Inc Capital Reinvestment Ratio (2025–2025)
This chart tracks Theravance Biopharma Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Theravance Biopharma Inc cash flow conversion.
Annual Capital Reinvestment Ratio for Theravance Biopharma Inc (2025–2025)
Year-by-year Capital Reinvestment Ratio for Theravance Biopharma Inc from 2025 to 2025. See Theravance Biopharma Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $238.54 Million | $42.00K | — |